博瑞医药：关于不提前赎回“博瑞转债”的公告

Core Viewpoint - The company, Borui Pharmaceutical, announced that it will not exercise the early redemption rights for its convertible bonds, known as "Borui Convertible Bonds," during the upcoming board meeting scheduled for September 11, 2025 [2]. Group 1 - The fourth session of the company's eleventh board meeting will take place on September 11, 2025 [2]. - The company has decided not to redeem the "Borui Convertible Bonds" early [2].